Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies in the world, for which the mortality is almost as high as the disease incidence and is predicted to be the second‐highest cause of cancer‐related deaths by 2030. These cancerous tumors consist of divers...
Main Authors: | Sooin Byeon, Taymin duToit‐Thompson, Josef Gillson, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Cancer Medicine |
Online Access: | https://doi.org/10.1002/cam4.6407 |
Similar Items
-
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
by: Sumit Sahni, et al.
Published: (2023-09-01) -
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
by: Josef Gillson, et al.
Published: (2020-05-01) -
Non-Surgical Interventions for the Prevention of Clinically Relevant Postoperative Pancreatic Fistula—A Narrative Review
by: Nadya Rykina-Tameeva, et al.
Published: (2023-12-01) -
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
by: Josef Gillson, et al.
Published: (2022-07-01) -
Synchronous Operable Pancreatic and Breast Cancer Without Genetic Mutation: A Literature Review and Discussion
by: Adam Ofri, et al.
Published: (2022-06-01)